The JAK2 inhibitor market focuses on targeted therapies used to treat myeloproliferative neoplasms and other hematological disorders. Growth is driven by rising disease prevalence, improved molecular diagnostics, and increasing adoption of precision medicine approaches. JAK2 inhibitors help regulate abnormal signaling pathways, reducing symptoms and disease progression. https://www.databridgemarketresearch.com/reports/global-jak2-inhibitor-market